Souba W W, McKenna R J, Meis J, Benjamin R, Raymond A K, Mountain C F
Cancer. 1986 Feb 1;57(3):610-5. doi: 10.1002/1097-0142(19860201)57:3<610::aid-cncr2820570336>3.0.co;2-p.
Sixteen patients are presented who had sarcomas of the chest wall at a site where a prior malignancy had been irradiated. The first malignancies included breast cancer (ten cases), Hodgkin's disease (four cases), and others (two cases). Radiation doses varied from 4200 to 5500 R (mean, 4900 R). The latency period ranged from 5 to 28 years (mean, 13 years). The histologic types of the radiation-induced sarcomas were as follows: malignant fibrous histiocytoma, nine cases; osteosarcoma, six cases; and malignant mesenchymoma, one case. The only long-term survivor is alive and well 12 years after resection of a clavicular chondroblastic osteosarcoma. Three cases were recently diagnosed. Despite aggressive multimodality treatment, the remaining 13 patients have all died from their sarcomas (mean survival, 13.5 months). All patients have apparently been cured of their first malignancies. Chemotherapy was ineffective. No treatment, including forequarter amputation, appeared to palliate the patients with supraclavicular soft tissue sarcomas. Major chest wall resection offered good palliation for seven of eight patients with sarcomas arising in the sternum or lateral chest wall. Close follow-up is needed to detect signs of these sarcomas in the ever-increasing number of patients receiving therapeutic irradiation.
本文报告了16例胸壁肉瘤患者,这些患者的胸壁肉瘤发生于曾接受过恶性肿瘤放疗的部位。首例恶性肿瘤包括乳腺癌(10例)、霍奇金病(4例)及其他(2例)。放疗剂量为4200至5500拉德(平均4900拉德)。潜伏期为5至28年(平均13年)。放疗诱发肉瘤的组织学类型如下:恶性纤维组织细胞瘤9例;骨肉瘤6例;恶性间叶瘤1例。唯一的长期存活者在锁骨软骨母细胞性骨肉瘤切除术后12年,仍健在且状况良好。3例为近期诊断。尽管采用了积极的多模式治疗,其余13例患者均死于肉瘤(平均生存期13.5个月)。所有患者的首例恶性肿瘤显然均已治愈。化疗无效。包括胸肩部截肢术在内的任何治疗,似乎均无法缓解锁骨上软组织肉瘤患者的症状。对于8例胸骨或胸侧壁肉瘤患者中的7例,胸壁大块切除术可提供良好的缓解。对于接受治疗性放疗的患者数量不断增加的情况,需要密切随访以发现这些肉瘤的迹象。